BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8816502)

  • 1. Functional interaction between DP-1 and p53.
    Sørensen TS; Girling R; Lee CW; Gannon J; Bandara LR; La Thangue NB
    Mol Cell Biol; 1996 Oct; 16(10):5888-95. PubMed ID: 8816502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression.
    Takahashi Y; Rayman JB; Dynlacht BD
    Genes Dev; 2000 Apr; 14(7):804-16. PubMed ID: 10766737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the E2F-1 transcription factor gene mediates cell transformation.
    Yang XH; Sladek TL
    Gene Expr; 1995; 4(4-5):195-204. PubMed ID: 7787412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315.
    Fogal V; Hsieh JK; Royer C; Zhong S; Lu X
    EMBO J; 2005 Aug; 24(15):2768-82. PubMed ID: 16037820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F-1 regulation by an unusual DNA damage-responsive DP partner subunit.
    Ingram L; Munro S; Coutts AS; La Thangue NB
    Cell Death Differ; 2011 Jan; 18(1):122-32. PubMed ID: 20559320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor.
    Dimri GP; Itahana K; Acosta M; Campisi J
    Mol Cell Biol; 2000 Jan; 20(1):273-85. PubMed ID: 10594030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.
    Altiok S; Xu M; Spiegelman BM
    Genes Dev; 1997 Aug; 11(15):1987-98. PubMed ID: 9271121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the Chlamydomonas cell cycle by a stable, chromatin-associated retinoblastoma tumor suppressor complex.
    Olson BJ; Oberholzer M; Li Y; Zones JM; Kohli HS; Bisova K; Fang SC; Meisenhelder J; Hunter T; Umen JG
    Plant Cell; 2010 Oct; 22(10):3331-47. PubMed ID: 20978220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis.
    Jordan-Sciutto KL; Wang G; Murphy-Corb M; Wiley CA
    Am J Pathol; 2000 Aug; 157(2):497-507. PubMed ID: 10934153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2f3 is critical for normal cellular proliferation.
    Humbert PO; Verona R; Trimarchi JM; Rogers C; Dandapani S; Lees JA
    Genes Dev; 2000 Mar; 14(6):690-703. PubMed ID: 10733529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription.
    Sharp TV; Munoz F; Bourboulia D; Presneau N; Darai E; Wang HW; Cannon M; Butcher DN; Nicholson AG; Klein G; Imreh S; Boshoff C
    Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16531-6. PubMed ID: 15542589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of p53-mediated apoptosis.
    Bates S; Vousden KH
    Cell Mol Life Sci; 1999 Jan; 55(1):28-37. PubMed ID: 10065149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting E2F1-DNA complexes with microgonotropen DNA binding agents.
    Chiang SY; Bruice TC; Azizkhan JC; Gawron L; Beerman TA
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):2811-6. PubMed ID: 9096302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAZ mediates G1 cell cycle arrest by interacting with and inhibiting E2F1.
    Yang M; Wu S; Jia J; May WS
    Cell Cycle; 2011 Jul; 10(14):2390-9. PubMed ID: 21715977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dp1 is largely dispensable for embryonic development.
    Kohn MJ; Leung SW; Criniti V; Agromayor M; Yamasaki L
    Mol Cell Biol; 2004 Aug; 24(16):7197-205. PubMed ID: 15282318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F/DP Prevents Cell-Cycle Progression in Endocycling Fat Body Cells by Suppressing dATM Expression.
    Guarner A; Morris R; Korenjak M; Boukhali M; Zappia MP; Van Rechem C; Whetstine JR; Ramaswamy S; Zou L; Frolov MV; Haas W; Dyson NJ
    Dev Cell; 2017 Dec; 43(6):689-703.e5. PubMed ID: 29233476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression.
    Zhou Y; Nakajima R; Shirasawa M; Fikriyanti M; Zhao L; Iwanaga R; Bradford AP; Kurayoshi K; Araki K; Ohtani K
    Biology (Basel); 2023 Dec; 12(12):. PubMed ID: 38132337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proline-rich motif in p53 is required for transactivation-independent growth arrest as induced by Gas1.
    Ruaro EM; Collavin L; Del Sal G; Haffner R; Oren M; Levine AJ; Schneider C
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4675-80. PubMed ID: 9114050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locally acting transcription factors regulate p53-dependent cis-regulatory element activity.
    Catizone AN; Uzunbas GK; Celadova P; Kuang S; Bose D; Sammons MA
    Nucleic Acids Res; 2020 May; 48(8):4195-4213. PubMed ID: 32133495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2.
    Rajagopalan S; Andreeva A; Rutherford TJ; Fersht AR
    Proc Natl Acad Sci U S A; 2010 May; 107(19):8587-92. PubMed ID: 20421506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.